Logo Loading...

Phone: +91 7499180452

Oncology Clinical Trial Monitor Market by Size, Share, Types (Lung Cancer, Breast Cancer, Leukemia, Prostate Cancer), Applications and Forecasts by 2029

Global Oncology Clinical Trial Monitor market was valued at around USD 10.8 million in 2019 and is expected to grow with the CAGR of 10.8% during forecast period 2021-2029.

Nowadays a business needs to move at the speed of their consumers. Keep a track of consumer needs and perspectives, and respond to market trends, to generate profitable business while using the right solutions at the right time.

Oncology Clinical Trial Monitor Industry Report Scope

The research study focuses on enhancing the basic knowledge of the market professionals about the main product/service, by explicating details like definition, its uses and applications, industry segmentation as well as a global industry outlook. The report further helps in making sound investment decision by listing factors that will contribute to the growth of market worldwide. The study also details about the foreign trade of the product along with the list of major importing and top exporting countries. The research study will also help understand graphical representation and forecasts of key data.

Market Segmentation

Minds Insights provides an analysis of the key trends in each segment of the Oncology Clinical Trial Monitor-market report, along with forecasts for growth at the region, country and global level from 2021-2029. Our report has categorized the market based on type, application and region.

On the basis of the Cancer Type:

  • Lung Cancer
  • Breast Cancer
  • Leukemia
  • Prostate Cancer
  • Other Cancer Types

On the basis of the Application:

  • Application 1
  • Application 2

Important regions covered:

  • North America: USA | Canada
  • Europe: UK | Germany | France |Spain | Italy | Russia | Netherlands | Belgium | Switzerland | Rest of Europe
  • Asia-Pacific: China | Japan | India |South Korea | Australia | Indonesia | Thailand | Philippines | Vietnam | Rest of Asia-Pacific
  • LAMEA: Brazil| Mexico | Argentina | Colombia | Chile | Peru | Rest of LAMEA
  • Middle East: Turkey | Saudi Arabia | United Arab Emirates| South Africa| Israel | Egypt |Nigeria | Rest of Middle East

Competitive Analysis

The report also includes key company profiles in Oncology Clinical Trial Monitor Industry with their market strategies and SWOT analysis. The report focuses on the industry’s main competitors with information such as business profiles, components and financial information of the past 5 years, and key developments. The competitive landscape of the industry has been examined along with the profiles of the key players:

  • IQVIA
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC
  • Charles River Laboratory
  • ICON Plc
  • PRA Health Sciences
  • Syneos Health
  • Medpace
  • Novotech
  • Pivotal

The report describes prominent players in the Oncology Clinical Trial Monitor market segment along with their basic profile, company information and recent developments. The report includes crucial information like manufacturing process, raw material requirements and supply-demand side. For investors, and new ventures the report includes information such as costs involved, revenue, market share and size, growth prospects involved.

Major factors covered in this report

  • Market Dynamics: Market Drivers and Restraints
  • Value-Chain: Supply and Demand Analysis
  • Cost and Price Structure Analysis
  • Competitive Analysis
  • Porter’s Five Forces Analysis

What will the report include?

  • Highlights of main global R&D activities and new technological developments
  • Estimation of the actual market size and revenue forecasts for global market
  • Description of the most relevant research and development activities related to Oncology Clinical Trial Monitor market places
  • Production of Oncology Clinical Trial Monitor, and review of application for Oncology Clinical Trial Monitor and assessment of emerging applications
  • Analyses of the global market trends, with data from 2020, estimates for 2021, and forecast through 2029
  • Review of current industry players, including manufacturers of Oncology Clinical Trial Monitor, technology developments, and future market participants

Some of the key questions addressed in the report were…

  • What were the market size in 2014 and the outlook from 2021 to 2029?
  • How much growth will the industry market experience between 2017 and 2029?
  • What are the important factors, constraints, and opportunities, and how they will affect market?
  • What are the key segments of the Oncology Clinical Trial Monitor market growth and why?
  • Who are the main participants and strategies they use to compete in the market?

Our reports are comprised of thorough analysis which includes business scientific analysis, data engineering, behavioural analysis experts and data strategy statistics based in 15 markets around the world. We use data and intelligence to help our clients build long-term relationship with their consumer.

Minds Insights is the foundation for data driven insights in various industry verticals using four key capabilities:

  • Qualitative Research
  • Quantitative Research
  • Strategy Building
  • Research Design

1 Introduction

  • Research Scope
  • Research Methodology and Assumptions
  • Market Segmentation
  • Definitions

2 Executive Summary

3 Market Overview

  • Market Segmentation & Scope
  • Value Chain Analysis
  • Supply Chain Analysis
  • Porter’s Five Forces Analysis
  • Regulatory Landscape 
  • Macro-Economic Indicators
  • Cost Structure Analysis
  • Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunities
  4. Market Evaluation

4 Impact of COVID-19 on the Market

5 Technical Analysis

  • Technical advances
  • Upcoming Technical Landscape

6 Competitive Analysis

  • Market Share Analysis
  • Potential Venture Analysis
  • Key Winning Strategies

7 Pricing Analysis

  • Regional Price Analysis
  • Raw Material Analysis

8 Oncology Clinical Trial Monitor Market, By Type Overview

  • Lung Cancer    
    1. Oncology Clinical Trial Monitor Market – By Type Analysis
    2. Global Oncology Clinical Trial Monitor Market Share, By Type, 2019 & 2026 (USD Million)
  • Breast Cancer    
    1. Oncology Clinical Trial Monitor Market – By Type Analysis
    2. Global Oncology Clinical Trial Monitor Market Share, By Type, 2019 & 2026 (USD Million)
  • Leukemia    
    1. Oncology Clinical Trial Monitor Market – By Type Analysis
    2. Global Oncology Clinical Trial Monitor Market Share, By Type, 2019 & 2026 (USD Million)
  • Prostate Cancer    
    1. Oncology Clinical Trial Monitor Market – By Type Analysis
    2. Global Oncology Clinical Trial Monitor Market Share, By Type, 2019 & 2026 (USD Million)

9 Oncology Clinical Trial Monitor Market, By Applications Overview

  • Application 1
    1. Global Oncology Clinical Trial Monitor Market Share, By Application, 2019 & 2026 (USD Million)
  • Application 2
    1. Global Oncology Clinical Trial Monitor Market Share, By Application, 2019 & 2026 (USD Million)

10  Regional Overview

  • Overview
  1. North America
    • United States
    • Canada
    • Mexico
  2. Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
  1. Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  1. Rest of the World
  • Latin America
  • Middle East and Africa

11  Competitive Landscape (Manufacturers & Suppliers)

INTRODUCTION (Business Overview, Platform, Solutions & Services, Key Insights, Recent Developments, SWOT Analysis)

  • IQVIA
    1. Company Overview
    2. Product/Service Portfolio
    3. IQVIA Sales, Revenue, and Gross Margin
    4. IQVIA Revenue and Growth Rate
    5. IQVIA Oncology Clinical Trial Monitor Market Share
  • PAREXEL International Corporation
    1. Company Overview
    2. Product/Service Portfolio
    3. PAREXEL International Corporation Sales, Revenue, and Gross Margin
    4. PAREXEL International Corporation Revenue and Growth Rate
    5. PAREXEL International Corporation Oncology Clinical Trial Monitor Market Share
  • Pharmaceutical Product Development LLC
    1. Company Overview
    2. Product/Service Portfolio
    3. Pharmaceutical Product Development LLC Sales, Revenue, and Gross Margin
    4. Pharmaceutical Product Development LLC Revenue and Growth Rate
    5. Pharmaceutical Product Development LLC Oncology Clinical Trial Monitor Market Share
  • Charles River Laboratory
    1. Company Overview
    2. Product/Service Portfolio
    3. Charles River Laboratory Sales, Revenue, and Gross Margin
    4. Charles River Laboratory Revenue and Growth Rate
    5. Charles River Laboratory Oncology Clinical Trial Monitor Market Share
  • ICON Plc
    1. Company Overview
    2. Product/Service Portfolio
    3. ICON Plc Sales, Revenue, and Gross Margin
    4. ICON Plc Revenue and Growth Rate
    5. ICON Plc Oncology Clinical Trial Monitor Market Share
  • PRA Health Sciences
    1. Company Overview
    2. Product/Service Portfolio
    3. PRA Health Sciences Sales, Revenue, and Gross Margin
    4. PRA Health Sciences Revenue and Growth Rate
    5. PRA Health Sciences Oncology Clinical Trial Monitor Market Share
  • Syneos Health
    1. Company Overview
    2. Product/Service Portfolio
    3. Syneos Health Sales, Revenue, and Gross Margin
    4. Syneos Health Revenue and Growth Rate
    5. Syneos Health Oncology Clinical Trial Monitor Market Share
  • Medpace
    1. Company Overview
    2. Product/Service Portfolio
    3. Medpace Sales, Revenue, and Gross Margin
    4. Medpace Revenue and Growth Rate
    5. Medpace Oncology Clinical Trial Monitor Market Share
  • Novotech
    1. Company Overview
    2. Product/Service Portfolio
    3. Novotech Sales, Revenue, and Gross Margin
    4. Novotech Revenue and Growth Rate
    5. Novotech Oncology Clinical Trial Monitor Market Share
  • Pivotal
    1. Company Overview
    2. Product/Service Portfolio
    3. Pivotal Sales, Revenue, and Gross Margin
    4. Pivotal Revenue and Growth Rate
    5. Pivotal Oncology Clinical Trial Monitor Market Share

12  Conclusion & Recommendation

13  Analyst Review

14  Research Methodology

Fig.1    Product Picture of Oncology Clinical Trial Monitor

Fig.2    Global Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.3    Global Oncology Clinical Trial Monitor Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)

Fig.4    Global Oncology Clinical Trial Monitor Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)

Fig.5    COVID-19 Impacts on Oncology Clinical Trial Monitor Market

Fig.6    COVID-19 Impact on the Players

Fig.7    Business Strategies and Recommendations

Fig.8    Global Oncology Clinical Trial Monitor Market Share, By Type, 2019 & 2026 (USD Million)

Fig.9    Global Lung Cancer Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.9    Global Breast Cancer Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.9    Global Leukemia Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.9    Global Prostate Cancer Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.10  Global Oncology Clinical Trial Monitor Market Share, By Application, 2019 & 2026 (USD Million)

Fig.11  Global Application 1 Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.11  Global Application 2 Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.12  Global Oncology Clinical Trial Monitor Market Share, by Region, 2019 & 2026 (USD Million)

Fig.13  North America Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.14  U.S. Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.15  Canada Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.16  Europe Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.17  Germany Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.18  France Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.19  U.K. Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.20  Italy Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.21  Spain Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.22  Portugal Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.23  Cyprus Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.24  Lithuania Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.25  Greece Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.26  Rest of Europe Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.27  Asia Pacific Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.28  China Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.29  Japan Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.30  India Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.31  South Korea Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.32  Rest of Asia Pacific Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.33  Latin America Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.34  Brazil Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.35  Mexico Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.36  Rest of Latin America Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.37  The Middle-East and Africa Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.38  GCC Countries Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.39  South Africa Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.40  Rest of Middle-East Africa Oncology Clinical Trial Monitor Market, 2016 – 2026 (USD Million)

Fig.41  Competitor Market Share – Revenue

Fig.42  IQVIA Revenue and Growth Rate

Fig.43  IQVIA Market Share

Fig.44   PAREXEL International Corporation Revenue and Growth Rate

Fig.45   PAREXEL International Corporation Market Share

Fig.46   Pharmaceutical Product Development LLC Revenue and Growth Rate

Fig.47   Pharmaceutical Product Development LLC Market Share

Fig.48   Charles River Laboratory Revenue and Growth Rate

Fig.49   Charles River Laboratory Market Share

Fig.50   ICON Plc Revenue and Growth Rate

Fig.51   ICON Plc Market Share

Fig.52   PRA Health Sciences Revenue and Growth Rate

Fig.53   PRA Health Sciences Market Share

Fig.54   Syneos Health Revenue and Growth Rate

Fig.55   Syneos Health Market Share

Fig.56   Medpace Revenue and Growth Rate

Fig.57   Medpace Market Share

Fig.58   Novotech Revenue and Growth Rate

Fig.59   Novotech Market Share

Fig.60   Pivotal Revenue and Growth Rate

Fig.61   Pivotal Market Share

Fig.82  Global Oncology Clinical Trial Monitor Market – Value Chain Analysis

Fig.83  Technology Roadmap and Timeline

Fig.84  Market Attractiveness Analysis – By Installation

Fig.85  Market Attractiveness Analysis – By Application

Fig.86  Market Attractiveness Analysis – By Region

 

List of Tables

Table 1 Global Oncology Clinical Trial Monitor Market, 2019 & 2026 (USD Million)

Table 2 Global Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 3 Global Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 4 Global Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 5 Global Oncology Clinical Trial Monitor Market, by Region, 2016 – 2026 (USD Million)

Table 6 North America Oncology Clinical Trial Monitor Market, by Country, 2016 – 2026 (USD Million)

Table 7 North America Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 8 North America Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 9 North America Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 10 Europe Oncology Clinical Trial Monitor Market, by Country, 2016 – 2026 (USD Million)

Table 11 Europe Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 12 Europe Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 13 Europe Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 14 Asia Pacific Oncology Clinical Trial Monitor Market, by Country, 2016 – 2026 (USD Million)

Table 15 Asia Pacific Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 16 Asia Pacific Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 17 Asia Pacific Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 18 Latin America Oncology Clinical Trial Monitor Market, by Country, 2016 – 2026 (USD Million)

Table 19 Latin America Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 20 Latin America Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 21 Latin America Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 22 The Middle-East and Africa Oncology Clinical Trial Monitor Market, by Country, 2016 – 2026 (USD Million)

Table 23 The Middle-East and Africa Oncology Clinical Trial Monitor Market, By Type, 2016 – 2026 (USD Million)

Table 24 The Middle-East and Africa Oncology Clinical Trial Monitor Market, By Installation, 2016 – 2026 (USD Million)

Table 25 The Middle-East and Africa Oncology Clinical Trial Monitor Market, By Application, 2016 – 2026 (USD Million)

Table 26 Global Oncology Clinical Trial Monitor Market - Company Revenue Analysis, 2016 – 2019 (USD Million)

Table 27 Global Oncology Clinical Trial Monitor Market - Company Revenue Share Analysis, 2016 – 2019 (%)

Table 28 Acquisitions and Mergers

Table 29 Market Drivers – Impact Analysis

Table 30 Market Restraints

Table 31 Market Opportunities